SERS spectroscopy was employed to study the interaction of the antitumoral drug paclitaxel with human serum albumin.
The normal Raman spectrum of the paclitaxel was shown in this study for the first time. There were some differences
existing in the surface-enhanced Raman scattering (SERS) spectrum of paclitaxel and its human serum albumin (HSA),
which demonstrated that there was high bioaffinity of paclitaxel to human serum albumin. And it was also found that
there existed some differences in the SERS of the paclitaxel/HSA complexes at different pH values, which may indicated
some significant information on the binding site, by which paclitaxel binds to human serum albumin. It can provide
significant instruction in the synthesis of the drug and in improving the therapeutic efficacy of this drug.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.